The present invention relates to 5-Aryltetrazole Compounds, compositions
comprising an effective amount of a a 5-Aryltetrazole Compound, and
methods for treating an inflammation disease, a reperfusion disease, or
hyperuricemia in an animal in need thereof comprising administering to
the animal an effective amount of a 5-Aryltetrazole compound.
